Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis A vaccines.

K Nor Shahidah1

  • 1National Institute for Natural Products, Vaccines & Biologicals, Ministry of Health Malaysia, Malaysia.

The Medical Journal of Malaysia
|August 20, 2005
PubMed
Summary

Hepatitis A vaccines offer long-term protection against this common liver infection, with immunity likely lasting over 25 years. Vaccination, alongside health education and sanitation, is key to preventing disease and outbreaks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chronic hepatitis B and herbal therapy.

The Medical journal of Malaysiaยท2005
See all related articles

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Vaccinology

Background:

  • Hepatitis A is a prevalent, vaccine-preventable liver infection globally.
  • Vaccines for Hepatitis A have been available since 1992, demonstrating high quality and safety.

Purpose of the Study:

  • To review the efficacy and long-term impact of Hepatitis A vaccination.
  • To inform strategies for large-scale immunization programs.

Main Methods:

  • Analysis of vaccine effectiveness and duration of immunity.
  • Review of safety data and outbreak interruption capabilities.
  • Consideration of mathematical modeling for antibody persistence.

Main Results:

  • Hepatitis A vaccines provide long-term immunity, with antibody persistence estimated beyond 25 years.
  • Vaccines are well-tolerated with no serious adverse events reported.
  • Successful use in protecting populations and controlling outbreaks in closed communities.

Conclusions:

  • Hepatitis A vaccination is a highly effective strategy for disease prevention.
  • Immunization programs should integrate health education and sanitation improvements.
  • Epidemiological and cost-benefit analyses are crucial for planning large-scale vaccination efforts.

Related Experiment Videos